BCM
CELG

Bridgeway Capital Management’s Celgene Corp CELG Stock Holding History

Bridgeway Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-53,000
Closed -$3.1M – 1548
2013
Q2 		$3.1M Buy
+53,000
New +$3.19M 0.12% 174

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bridgeway Capital Management's CELG Position: Q3 2013 in Review

Bridgeway Capital Management sold out of Celgene Corp (CELG) in Q3 2013, closing a stake of 53,000 shares — an estimated $3.1M sold.

Bridgeway Capital Management first reported a position in CELG in Q2 2013 and held it in 1 quarter. The position peaked at $3.1M in Q2 2013. 909 funds tracked by Wall St. Rank hold CELG as of Q3 2013.

  • Bridgeway Capital Management reported no remaining Celgene Corp position as of Q3 2013 after selling out during the quarter.
  • Bridgeway Capital Management sold 53,000 Celgene Corp shares in Q3 2013, an estimated $3.1M.
  • Bridgeway Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 1 quarter.
  • Bridgeway Capital Management's Celgene Corp position peaked at $3.1M in Q2 2013.
  • 909 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2013.

Based on Bridgeway Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.